z-logo
open-access-imgOpen Access
Spliced HLA‐bound peptides: a Black Swan event in immunology
Author(s) -
Faridi P.,
Dorvash M.,
Purcell A. W.
Publication year - 2021
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/cei.13589
Subject(s) - proteome , human leukocyte antigen , biology , proteolysis , alternative splicing , immune system , rna splicing , computational biology , peptide , immunology , microbiology and biotechnology , genetics , antigen , biochemistry , gene , rna , messenger rna , enzyme
Summary Peptides that bind to and are presented on the cell surface by human leucocyte antigen (HLA) molecules play a critical role in adaptive immunity. For a long time it was believed that all the HLA‐bound peptides were generated through simple proteolysis of linear sequences of cellular proteins, and therefore are templated in the genome and proteome. However, evidence for untemplated peptide ligands of HLA molecules has accumulated during the last two decades, with a recent global analysis of HLA‐bound peptides suggesting that a considerable proportion of HLA‐bound peptides are potentially generated through splicing/fusion of discontinuous peptide segments from one or two distinct proteins. In this review, we will evaluate recent discoveries and debates on the contribution of spliced peptides to the HLA class I immunopeptidome, consider biochemical rules for splicing and the potential role of these spliced peptides in immune recognition.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom